Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Menz

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
BMC Cancer|July 3, 2024
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumorsSimon Kind, Carolina Palacios Castillo, Ria Schlichter, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 2026
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor typesFlorian Viehweger, Paul Wirth, Natalia Gorbokon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 29, 2022
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligenceDavid Dum, Tjark L C Henke, Tim Mandelkow, et al.
Scientific Reports|August 9, 2023
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroidMaximilian Lennartz, Henrietta Csomós, Viktoria Chirico, et al.
Plos One|June 28, 2023
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreasRia Uhlig, Nina Bröker, Sören Weidemann, et al.
The American Journal of Surgical Pathology|August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor TypesNatalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Plos One|April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumorsSeyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
BMC Cancer|July 3, 2024
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumorsSimon Kind, Carolina Palacios Castillo, Ria Schlichter, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 2026
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor typesFlorian Viehweger, Paul Wirth, Natalia Gorbokon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 29, 2022
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligenceDavid Dum, Tjark L C Henke, Tim Mandelkow, et al.
Scientific Reports|August 9, 2023
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroidMaximilian Lennartz, Henrietta Csomós, Viktoria Chirico, et al.
Plos One|June 28, 2023
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreasRia Uhlig, Nina Bröker, Sören Weidemann, et al.
The American Journal of Surgical Pathology|August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor TypesNatalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Plos One|April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumorsSeyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Pageof 8